Related Experiment Video
Updated: May 5, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
Targeting Hypertension: A Review on Pathophysiological Factors and Treatment Strategies
Ruhani Raj1, Minakshi Garg1, Anupreet Kaur1
1Department of Biotechnology, UIET, Panjab University, Chandigarh, India.
Insights
Hypertension significantly increases cardiovascular disease risks. Effective management involves lifestyle changes and medication, crucial for reducing mortality, especially in underserved regions.
Area of Science:
- Cardiology
- Public Health
- Nephrology
Background:
- Hypertension is a leading cause of cardiovascular diseases (CVD) and mortality globally.
- Prevalence is higher in low- and middle-income countries, posing a significant public health challenge.
- While 2-5% of cases stem from renal or adrenal disorders, most are essential hypertension with complex pathophysiology.
Purpose of the Study:
- To outline the risks associated with hypertension, including CVD events like heart attack, heart failure, and stroke.
- To detail current first-line management strategies for hypertension, emphasizing lifestyle modifications and pharmacotherapy.
- To highlight the need for improved access to diagnosis, treatment, and interventions.
Main Methods:
- Review of existing literature on hypertension pathophysiology, risk factors, and treatment guidelines.
- Analysis of the additive effects of lifestyle interventions on blood pressure reduction.
- Evaluation of criteria for initiating antihypertensive medication based on blood pressure levels and CVD risk.
Main Results:
- Lifestyle changes (diet, exercise, weight loss, reduced alcohol) are foundational, with additive blood pressure-lowering effects.
- Antihypertensive medication choices include thiazide diuretics, ACE inhibitors/ARBs, and calcium channel blockers.
- Treatment decisions are guided by blood pressure severity and atherosclerotic CVD risk.
Conclusions:
- Comprehensive management of hypertension requires integrating lifestyle interventions with appropriate pharmacotherapy.
- Addressing disparities in access to diagnosis and treatment is critical for controlling hypertension worldwide.
- Continued research and public health initiatives are necessary to combat the global burden of hypertension.
Abstract:
Hypertension is one of the primary causes of cardiovascular diseases and death, with a higher prevalence in low- and middle-income countries. The pathophysiology of hypertension remains complex, with 2% to 5% of patients having underlying renal or adrenal disorders. The rest are referred to as essential hypertension, with derangements in various physiological mechanisms potentially contributing to the development of essential hypertension. Hypertension elevates the risk of cardiovascular disease (CVD) events (coronary heart disease, heart failure, and stroke) and mortality. First-line therapy for hypertension is lifestyle change, which includes weight loss, a balanced diet that includes low salt and high potassium intake, physical exercise, and limitation or elimination of alcohol use. Blood pressure-lowering effects of individual lifestyle components are partially additive, enhancing the efficacy of pharmaceutical treatment. The choice to begin antihypertensive medication should be based on the level of blood pressure and the existence of a high atherosclerotic CVD risk. First-line hypertension treatment includes a thiazide or thiazide-like diuretic, an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, and a calcium channel blocker. Addressing hypertension will require continued efforts to improve access to diagnosis, treatment, and lifestyle interventions.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management

